Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI. XTANDI® (enzalutamide) capsules, for oral useXTANDI® (enzalutamide) tablets, for oral useInitial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
XTANDI® is indicated for the treatment of patients with: •castration-resistant prostate cancer (CRPC) •metastatic castration-sensitive prostate cancer (mCSPC) •non‑metastatic castration‑sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis (high-risk BCR)
- generic_name
- enzalutamide
- product_names
- enzalutamide
- ndc
- 0469-0125, 0469-0125-99, 0469-0625, 0469-0625-99, 0469-0725, 0469-0725-60, 0469-1125, 0469-1125-56, 0469-1725, 0469-1725-56
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en